Burt A. Adelman M.D.
Net Worth
Last updated:
What is Burt A. Adelman M.D. net worth?
The estimated net worth of Dr. Burt A. Adelman M.D. is at least $449,440 as of 12 May 2022. He owns shares worth $209,440 as insider and has received compensation worth at least $240,000 in Verve Therapeutics, Inc..
What is the salary of Burt A. Adelman M.D.?
Dr. Burt A. Adelman M.D. salary is $60,000 per year as Co-Founder & Independent Chairman in Verve Therapeutics, Inc..
How old is Burt A. Adelman M.D.?
Dr. Burt A. Adelman M.D. is 73 years old, born in 1952.
What stocks does Burt A. Adelman M.D. currently own?
As insider, Dr. Burt A. Adelman M.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Verve Therapeutics, Inc. (VERV) | Co-Founder & Independent Chairman | 18,700 | $11.2 | $209,440 |
What does Verve Therapeutics, Inc. do?
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Burt A. Adelman M.D. insider trading
Verve Therapeutics key executives
Verve Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Andrew Bellinger M.D., Ph.D. (47) Chief Scientific Officer & Chief Medical Officer
- Dr. Burt A. Adelman M.D. (73) Co-Founder & Independent Chairman
- Dr. Sekar Kathiresan M.D. (53) Co-Founder, Chief Executive Officer & Director
- Mr. Andrew D. Ashe J.D. (58) Pres & Chief Operating Officer